Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Castle Biosciences Inc at Needham Healthcare Conference Transcript

Apr 15, 2020 / 07:30PM GMT
Release Date Price: $29.69 (-0.67%)
Steve Unger
Needham & Company - Analyst

Good afternoon, everyone, and welcome to the final day of the 19th annual Needham Healthcare Conference. My name is Steve Unger and it is my pleasure to host our next presentation in the cancer diagnostics track, Castle Biosciences. Joining me today is Chief Executive Officer Derek Maetzold, and Chief Financial Officer Frank Stokes, as well as Camilla Zuckero who is the Company's Executive Director, Investor Relations.

In terms of the format for the session, Derek is going to provide a brief -- a business overview with slides, and then Camilla will moderate the Q&A. (Operator Instructions). With that I will drop off and hand the platform over to Derek.

Derek Maetzold
Castle Biosciences, Inc. - Founder, President & CEO

Thank you, Steve. I appreciate the introductions and the opportunity to participate in maybe the first annual virtual healthcare conference webcast for the 19th annual meeting. I will start off by going through our corporate presentation deck and try and hit some of the main

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot